Senescent microglia accumulate in aged brain white matter and can be identified through spatial mapping techniques. Senotherapeutic interventions reduce this accumulation, suggesting a tractable target for preserving neurological function during aging.
Key Points
- Senescent microglia concentrate in white matter regions of aged brains
- Spatial transcriptomics identifies disease-associated microglial states precisely
- Senotherapeutic drugs reduce senescent microglial burden in aged tissue
Longevity Analysis
Brain aging involves accumulation of dysfunctional immune cells that impair the structural and functional integrity of white matter—the neural highways responsible for communication between brain regions. The ability to map and selectively target these senescent cells opens a mechanistic pathway for intervention. Rather than treating aging as inevitable neurological decline, this work demonstrates that specific cellular states driving that decline can be reversed, shifting the aging trajectory at a systems level. For practitioners and patients, this validates the therapeutic potential of removing what interferes with healthy neural aging, rather than only attempting to compensate for damage after it occurs.
Original published by Nature Aging, by Chase M. Carver.